Andere Sprachen Ultimovacs ASA

Aktien

A2PKSD

NO0010851603

ULTI

Markt geschlossen - Oslo Bors Andere Börsenplätze 16:45:00 30.04.2024			% 5 Tage	% 1. Jan.
6,98 ^NOK	+0,29 %		-11,65 %	-94,32 %

17.04.	Transcript : Ultimovacs ASA - Special Call
16.04.	Ultimovacs ASA nimmt operative Anpassungen vor, um die kontinuierliche Weiterentwicklung des Phase-II-Programms für den UV1-Impfstoff zu unterstützen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation	30.04.
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24.04.
Ultimovacs ASA – Annual General Meeting held on April 18, 2024	18.04.
Ultimovacs to Reduce 40% of Workforce Amid Operational Adjustments	17.04.
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16.04.
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16.04.
Ultimovacs ASA Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16.04.
Ultimovacs - Invitation to Business Update on April 17, 2024	09.04.
Ultimovacs – Invitation to Business Update on April 17, 2024	09.04.
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024	04.04.
Ultimovacs : TENDU trial Poster presentation at AACR 2024	02.04.
Ultimovacs : Company Presentation as per March 23, 2024	25.03.
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024	25.03.
Ultimovacs ASA: Mandatory notification of trade by primary insider	22.03.
Ultimovacs ASA: Mandatory notification of trade by primary insider	22.03.
Ultimovacs ASA: Annual Report 2023	21.03.
Ultimovacs ASA: Mandatory notification of trades by primary insider	09.03.
Ultimovacs ASA: Mandatory notification of trades by primary insider	08.03.
Ultimovacs ASA: Mandatory notification of trades by primary insider	08.03.
Ultimovacs ASA - Mandatory trade notification and disclosure of holding	08.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ultimovacs ASA

Aktien

A2PKSD

NO0010851603

ULTI

Andere Sprachen

Filter